Key Developments: McKesson Corp (MCK.N)

MCK.N on New York Stock Exchange

217.67USD
23 Jan 2015
Change (% chg)

-- (--)
Prev Close
$217.67
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
225,598
52-wk High
$219.65
52-wk Low
$162.90

Search Stocks

Latest Key Developments (Source: Significant Developments)

McKesson Corp launches takeover offer for remaining Celesio shares
Friday, 28 Feb 2014 09:05am EST 

McKesson Corp:Launched voluntary public takeover offer for remaining outstanding shares of Celesio AG through its indirect wholly-owned subsidiary Dragonfly GmbH & Co. KGaA.There are no closing conditions in relation to the Takeover Offer.McKesson exceeds 75 pct ownership of Celesio shares on fully diluted basis.  Full Article

McKesson Corp and Rite Aid expand distribution agreement
Tuesday, 18 Feb 2014 08:45am EST 

McKesson Corp and Rite Aid Corp:Signs of an expanded distribution agreement to include both brand and generic pharmaceuticals.Says new five-year agreement, which extends through March 2019, creates efficiencies for both companies by leveraging the strength.Says agreement leverages the strength of Rite Aid national drugstore chains in the United States and McKesson as a leader in pharmaceutical sourcing and supply chain management.  Full Article

McKesson Corp completes previously announced agreements, secures Celesio Acquisition
Thursday, 6 Feb 2014 09:00am EST 

McKesson Corp:Says it has completed the previously announced agreement with Franz Haniel & Cie. GmbH to acquire their entire holding of Celesio AG shares.Says it has also confirmed it has completed the previously announced agreement with an affiliate of Elliott Management to acquire Celesio convertible bonds.Says it now exceeds 75 pct ownership of Celesio shares on a fully diluted basis.  Full Article

McKesson Corp lowers FY 2014 EPS guidance
Thursday, 30 Jan 2014 04:10pm EST 

McKesson Corp:Says third-quarter performance of distribution solutions segment where adjusted operating profit grew by 37pct and full-year view of the performance in distribution solutions is better than previous expectations.Says this operating strength is offset by an increase in tax reserves due to a dispute with the Canadian tax authorities and a charge in Technology Solutions segment as it continue to align its Horizon Clinicals software platform development efforts and size the organization appropriately.Says as a result, it is updating previous outlook and expects adjusted earnings per diluted share of $8.05 to $8.20 for the FY 2014.FY 2014 EPS of $8.63 - Thomson Reuters I/B/E/S.  Full Article

McKesson Corp declares quarterly dividend
Wednesday, 29 Jan 2014 04:10pm EST 

McKesson Corp:Declares a regular dividend of $0.24 per share on Common Stock.Says dividend will be payable on Apr. 1 to stockholders of record on Mar. 3.  Full Article

McKesson Corp subsidiary makes voluntary public takeover offer to the shareholders of Celesio AG
Thursday, 23 Jan 2014 05:00pm EST 

McKesson Corp:Announces that it 100 percent subsidiary, Dragonfly GmbH & Co. KGaA (Dragonfly), today to make a voluntary public takeover offer to the shareholders of Celesio AG (the 'Takeover Offer') for the acquisition of their non-par-value registered shares in Celesio AG.Says Dragonfly intends to offer a consideration in cash of 23.50 euro per Celesio Share, and the Takeover Offer will not be subject to any completion conditions and will be made on the terms and conditions set forth in the offer document.  Full Article

McKesson Corp Declares Quarterly Dividend
Friday, 25 Oct 2013 04:10pm EDT 

McKesson Corp announced that it has declared a regular dividend of $0.24 per share on Common Stock. The dividend will be payable on January 2, 2014, to stockholders of record on December 2, 2013.  Full Article

McKesson Corp Raises FY 2014 EPS Guidance
Thursday, 24 Oct 2013 07:30am EDT 

McKesson Corp announced that for fiscal 2014, it expects adjusted earnings per diluted share (EPS) of $8.40 to $8.70. According to I/B/E/S Estimates, analysts on an average are expecting the Company to report EPS of $8.33 for fiscal 2014.  Full Article

McKesson Corp Announces Agreement To Purchase Celesio AG
Thursday, 24 Oct 2013 01:01am EDT 

McKesson Corp announced that McKesson has signed an agreement to acquire a majority stake in Celesio for EUR23 per share and to launch parallel voluntary public tender offers for the remaining publicly-traded shares and outstanding convertible bonds of Celesio. The total transaction, including the assumption of Celesio's outstanding debt, is valued at approximately $8.3 billion(EUR6.1 billion). Under the terms of a share purchase agreement between McKesson and Franz Haniel & Cie. GmbH (Haniel), the majority shareholder in Celesio, McKesson has agreed to acquire Haniel's stake in Celesio, currently representing 50.01% of the total outstanding shares of the Company. The share purchase agreement has been approved by McKesson's Board of Directors and Haniel's Supervisory Board.  Full Article

McKesson Corp Close To $7.6 Billion Bid For Celesio AG-Reuters
Wednesday, 23 Oct 2013 11:00am EDT 

Reuters reported that McKesson Corp is nearing a deal that would trigger a full takeover bid for German peer Celesio AG for close to EUR5.5 billion ($7.6 billion), two people close to the negotiations told Reuters on October 23, 2013. They said McKesson, was preparing to announce an offer of close to EUR23 per share as it concludes a deal to purchase 50.01% of Celesio's shares from diversified holding company Franz Haniel & Cie. McKesson is expected to make the announcement on October 24, 2013. Celesio declined to comment, while San Francisco-based McKesson was not immediately available for comment.  Full Article

Analytics-based U.S. tech firm Inovalon files for IPO

- Inovalon Holdings Inc, an analytics and data-based technology service provider to the healthcare sector, filed with U.S. regulators on Tuesday to raise up to $500 million in an initial public offering of Class A common stock.

Search Stocks